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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.08.068Objective: To investigate whether regional cerebral tissue oxygen saturation mon-
itoring during hypothermic selective antegrade cerebral perfusion in surgery involv-
ing the aortic arch can predict neurologic sequelae and to evaluate the diagnostic
performance of near-infrared spectroscopy monitoring in this setting.
Methods: Data from 46 consecutive patients were analyzed. Selective antegrade
cerebral perfusion was established by perfusion of the right subclavian artery (with
or without left carotid artery perfusion) or by separate concomitant perfusion of the
innominate and the left carotid arteries. The bilateral regional cerebral tissue oxygen
saturation index was monitored by using near-infrared spectroscopy equipment
(INVOS 4100). Stroke was the primary clinical end point, along with the indices of
diagnostic performance.
Results: Six patients died in the hospital, and 6 patients (13%) experienced a
perioperative stroke. In patients with stroke, regional cerebral tissue oxygen satu-
ration values were significantly lower during selective antegrade cerebral perfusion,
and regional cerebral tissue oxygen saturation tended to be lower in the affected
hemisphere. In receiver operating characteristic curve analysis, the area under the
curve for relative regional cerebral tissue oxygen saturation values ranged from 0.72
to 0.87. During selective antegrade cerebral perfusion, regional cerebral tissue
oxygen saturation between 76% and 86% of baseline had a sensitivity up to 83% and
a specificity up to 94% in identifying individuals with stroke. The associated odds
ratio for stroke was 5.6 (95% confidence interval, 0.5-144) to 21 (95% confidence
interval, 1.8-566).
Conclusions: Monitoring of regional cerebral tissue oxygen saturation by using
near-infrared spectroscopy during selective antegrade cerebral perfusion allows
detection of clinically important cerebral desaturation. It can help predict perioper-
ative neurologic sequelae. Its performance as a diagnostic instrument is satisfying
and supports its use as a noninvasive trend monitor of cerebral saturation.
In operations extending to the transverse aortic arch, selective antegrade cerebralperfusion (SACP) has been introduced and developed to decrease the potentialfor cerebral damage associated with the hypothermic circulatory arrest (HCA)
strategy.1 Aiming at increased safety and improved neurologic outcome, monitoring
of cerebral tissue oxygenation during SACP by near-infrared spectroscopy (NIRS),
among other techniques, has been used clinically.2-5 The NIRS equipment provides
monitoring of regional cerebral tissue oxygen saturation (rSO2) in a continuous,
noninvasive, and examiner-independent fashion. The results of clinical and exper-
imental use of NIRS monitoring have been promising,3,4,6-8 but opinions about its
dependency and usefulness have been equivocal.9-11 The diagnostic performance
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the method has not been reported in this patient group.
In this study, bilateral intraoperative NIRS monitoring
was used in patients undergoing operations involving the
aortic arch with the aid of SACP. The objective was to
examine the overall diagnostic performance of the NIRS
monitoring method in this clinical setting. The primary
goals were to evaluate the ability to predict perioperative
stroke and to test the hypothesis that a lower rSO2 is
associated with an increased stroke risk. Secondary goals
were to investigate the correlation between rSO2 and standard
monitoring (arterial blood gas components, mean arterial pres-
sure, and hematocrit) and to investigate the influence of the
SACP strategy (bilateral or unilateral cerebral perfusion) on
rSO2 values.
Patients and Methods
Patients and Definitions
The 46 patients were operated on consecutively between
January 2003 and September 2004, and data were analyzed
retrospectively. Inclusion criteria were operations involving
the aortic arch and cerebral protection with SACP. No
patient who met these criteria was excluded from analysis.
Computed tomography of the aorta was the mainstay of
diagnosis, and this was supplemented by echocardiography
as clinically indicated. Duplex scan of the carotid arteries
was not performed routinely. Mortality was defined as all-
cause in-hospital mortality. Stroke was defined as any new
neurologic deficit that did not resolve before discharge and
that was confirmed with computed tomography, specialist
neurologic assessment, or both.
Surgery and SACP
Three different setups for SACP were used: (1) right-sided
unilateral SACP through a subclavian artery cannula, (2)
bilateral SACP through the combination of a right-sided
subclavian artery cannula and a separate left carotid artery
cannula, and (3) bilateral SACP through 2 separate cannulas
(DLP 15F coronary sinus cannula; Medtronic Inc, Minne-
apolis, Minn) in the innominate and left carotid arteries. The
choice of SACP strategy was nonrandomized and surgeon
driven. The subclavian artery was cannulated with a wire-
Abbreviations and Acronyms
AUC  area under the curve
CPB  cardiopulmonary bypass
HCA  hypothermic circulatory arrest
NIRS  near-infrared spectroscopy
ROC  receiver operating characteristic
rSO2  regional cerebral tissue oxygen saturation
SACP selective antegrade cerebral perfusionreinforced 18F to 22F femoral arterial cannula (FemFlex II
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Calif]). The left subclavian artery was not perfused. In most
cases it was left unclamped to verify back-bleeding and aid
in the deairing of the arch on completion of the distal
anastomosis. Venous return was obtained from a 2-stage right
atrial cannula or from a long 2-stage femoral vein cannula. The
proximal aorta was addressed during cooling to 18°C to 25°C
nasopharyngeal temperature. At the target temperature, with
the head packed in ice, the circulation was arrested and the
venous blood drained into the reservoir. After inspection of
the arch, the proximal innominate artery was snared, and
SACP was started at 250 to 500 mL/min. A second cannula
was added in the left carotid, and flow was increased to 500
to 1000 mL/min (approximately 10 mL · kg1 · min1, ac-
cording to previously reported findings12,13). In cases with-
out subclavian artery cannulation, right radial artery
pressure was maintained at 40 to 70 mm Hg to avoid
hypoperfusion and hyperperfusion12,13; otherwise, calcu-
lated flow was maintained and not corrected for nasopha-
ryngeal temperature. Acid-base balance was managed with
the alpha-stat strategy, and hematocrit was adjusted to reach
25% to 28% at the conclusion of cardiopulmonary bypass
(CPB), with blood transfusions as required. At completion
of the open distal anastomosis, the cannulas were removed,
the arch was carefully deaired, and CPB was recommenced,
either through the right subclavian artery cannula or by
cannulating the anastomosed tube graft.
Near-Infrared Spectroscopy
The principles of NIRS have been described in detail
previously.11,14,15 In brief, light in the 650- to 1100-nm
interval (i.e., including near-infrared light) is to the largest
extent absorbed in tissues by the oxygenated and deoxygen-
ated forms of hemoglobin. Hence, according to the modified
Lambert-Beer law, light absorbance is proportional to the
concentrations of these chromophores.14 From these con-
centrations, tissue saturation can be derived. The INVOS
4100 cerebral oximeter (Somanetics Corp, Troy, Mich) was
used for bilateral monitoring of rSO2 throughout the oper-
ations. Readings were obtained continuously and recorded
at prespecified time points. Two single-use adhesive patches
(Adult Soma Sensor SAFB; Somanetics Corp) were placed
on the forehead: the frontal sinuses, the sagittal sinus, and
the temporal muscles were avoided. Near-infrared light
was emitted from a light-emitting diode source and de-
tected at 2 separate distances (3 and 4 cm) to allow sub-
traction of the contribution to the signal by superficial
tissues. According to the manufacturer, on average 85% of
the signal is of cerebral origin. Two wavelengths (730 and
810 nm) are used to detect changes in hemoglobin oxygen-
ation. In the INVOS algorithm, calculation of rSO2 depends
on the relative contributions of venous and arterial compart-
ments, considered stable at a 75:25 ratio. The rSO2 readings
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unknown baseline. No other method of cerebral monitoring
was used.
Statistical Methods
No assumptions of normal distributions of the variables
were made, and nonparametric statistical tests were used:
Mann-Whitney U test (continuous variables) and Fisher
exact test (dichotomous variables). Changes in rSO2 were
expressed in relative terms as the percentage of baseline set
at 100% when stable conditions were reached on full-flow
TABLE 1. Preoperative variables of all patients, patients
without stroke, and patients with stroke
All
(n  46)
Stroke P
valueNo (n  40) Yes (n  6)
Men 31 (67%) 28 (70%) 3 (50%) .30
Age, y 61 (53-67) 59 (53-66) 66 (63-73) .09
Age 70 y 9 (20%) 7 (18%) 2 (33%) .33
Diagnosis
Acute A 25 (54%) 20 (50%) 5 (83%) .14
Chron A 5 (11%) 4 (10%) 1 (17%) .52
Asc Ane 14 (30%) 14 (35%) 0 10
Other* 2 (4%) 2 (5%) 0 .75
Acute 23 (50%) 19 (48%) 4 (67%) .33
Rupture 15 (33%) 15 (38%) 0 .15
EuroSCORE 9 (7-10) 8.5 (7-10.5) 9.5 (9-10) .43
EuroSCORE 8 17 (37%) 24 (60%) 5 (83%) .39
Stroke Hx 0 0 0 n/a
Numbers with percentages and medians with 25th and 75th centiles. Acute
A, Acute type A aortic dissection; Chron A, chronic type A aortic dissec-
tion; Asc Ane, ascending aortic aneurysm; Hx, history. *One aneurysm of
the arterial duct; one thoracoabdominal tumor.
TABLE 2. Perfusion-related variables for all patients, pa-
tients without stroke, and patients with stroke
Stroke
All (n  46) No (n  40) Yes (n  6) P value
CPB time, min 220 (192-286) 220 (188-289) 220 (210-230) .76
HCA time, min 38 (28-51) 38 (28-52) 37 (33-47) .84
SACP time,
min
32 (25-46) 33 (26-50) 25 (19-32) .06
Unperfused 29 (63%) 23 (58%) 6 (100%) .07
Unperfused
time, min
2 (0-11) 2 (0-10) 16 (7-18) .004
Bilateral
SACP
40 (87%) 37 (92%) 3 (50%) .004
Lowest body
temp, °C
20 (19-22) 20 (19-22) 20 (19-21) .64
Numbers with percentages and medians with 25th and 75th centiles. CPB,
Cardiopulmonary bypass; HCA, hypothermic circulatory arrest; SACP, se-
lective antegrade cerebral perfusion.
The Journal of Thoracinormothermic CPB. Calculation of the area under the curve
(AUC) of the receiver operating characteristic (ROC), with
95% confidence intervals, was used to evaluate diagnostic
accuracy16,17 by using a semiparametric method (Analyse-it
Software Ltd, Leeds, United Kingdom). Cutoff values for
the highest sensitivity and specificity were identified at each
time point in both hemispheres. On the basis of the cutoff
value, diagnostic performance indices (sensitivity, specific-
ity, positive predictive value, negative predictive value, and
positive and negative likelihood ratios) were calculated
(Appendix E1).
Results
The clinical characteristics of the patients are summarized
in Table 1. Six patients (13%) died in the hospital. The
cause of death was bleeding in 3, cardiac failure in 2, and
stroke in 1. None of the 5 patients dead of nonneurologic
complications showed signs of cerebral injury at autopsy.
Six patients (13%) had a perioperative stroke. In 1, it was
global (leading to death), in 3 it was left hemispheric, and in
Figure 1. The rSO2 relative to baseline (100%) in the (A) left and (B)
right hemispheres in patients without (n  40) and with (n  6)
stroke. Data are mean and SEM.2 it was right hemispheric. Excluding the patients with
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toms: seizures and impaired consciousness that resolved
gradually. One patient had bilateral optic nerve infarctions
after a free interval after surgery and was not included
among the stroke cases. The prevalence of periods of HCA
without ongoing SACP (termed unperfused brain), the me-
dian duration of such periods, and the use of unilateral
SACP were associated with perioperative stroke (Table 2).
Direct readings of the rSO2 index varied widely between
subjects and were not useful for group comparisons. When
expressed as percentage of baseline, a significant difference
was found in patients free from stroke compared with those
with stroke: in the latter, relative rSO2 was bilaterally sig-
nificantly reduced during SACP, to levels 65% to 80% of
baseline (Figure 1). In patients without stroke, only the left
hemispheric rSO2 at the beginning of SACP was signifi-
cantly decreased compared with baseline, whereas in stroke,
rSO2 in both hemispheres at all time points except for after
SACP in the right hemisphere was significantly lower than
Figure 2. The rSO2 relative to baseline (100%) in both hemispheres
in (A) left (n  3) and (B) right (n  2) hemispheric strokes. Data
are mean and SEM.baseline. In patients with left hemispheric strokes, relative
374 The Journal of Thoracic and Cardiovascular Surgery ● FebrrSO2 values were lower on the left side than on the right,
with a corresponding similar but less pronounced pattern for
right hemispheric strokes (Figure 2). Bilateral cerebral per-
fusion (n  40) resulted in higher rSO2 values in both
hemispheres throughout the operation compared with pa-
tients managed with unilateral SACP (n  6), with signif-
icantly higher right hemispheric readings at the onset of
SACP and at the conclusion of CPB (Figure 3).
ROC curves for rSO2 values of both hemispheres at
consecutive time points during SACP are illustrated in
Figure 4. The rSO2 at the onset of SACP displayed the best
diagnostic accuracy. Apart from values obtained at the end
of CPB, ROC curve AUCs were similar throughout opera-
tion and were significantly different from 0.5, as illustrated
in Table 3. Sensitivity reached a high 83% at the onset of
SACP, whereas specificity was highest, 94%, in right hemi-
spheric readings after SACP, albeit at a lower cutoff value
Figure 3. The rSO2 relative to baseline (100%) in the (A) left and (B)
right hemispheres with bilateral (n  37) and unilateral (n  9)
selective antegrade cerebral perfusion (SACP). Data are mean
and SEM.(77% of baseline). Overall, negative predictive values
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selective antegrade cerebral perfusion (SACP) (A), mid SACP (B), end of SACP (C), after SACP (D), and end of
cardiopulmonary bypass (CPB) (E).
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likelihood ratios were better than negative likelihood
ratios (Table 3).
In a handful of cases, rSO2 decreased suddenly because
of technical errors such as cannula dislodgment or arterial
line compromise, and this necessitated prompt countermea-
sures. Such episodes were temporary, and we did not iden-
tify any relationship to the rSO2 levels during the remainder
of the perfusion or to clinical outcome.
Intraoperative measurements of blood gas components
(pH, arterial partial pressure of oxygen and carbon dioxide,
base excess, arterial saturation, and hematocrit) and mean
arterial pressure showed no relation to neurologic outcome.
These variables correlated with values of rSO2 in either
hemisphere only vaguely and without a distinct pattern
(Table E1).
Discussion
Patients with perioperative stroke did not differ from stroke-
free individuals in preoperative characteristics. However,
patients with perioperative stroke more often had episodes
of unperfused brain (100% vs 58%), and the aggregated
time of unperfused brain was significantly longer in stroke
victims (16 vs 2 minutes, respectively). Stroke was more
common after a strategy of unilateral rather than bilateral
SACP (50% vs 7.5%; Table 2). These findings suggest a
higher risk of perioperative stroke in cases in which brain
protection, despite the use of SACP, was suboptimal, and
they reflect the vulnerability of patients undergoing aortic
arch operations.
With stroke, rSO2 was significantly lower bilaterally and
without interruption until after the completion of CPB (Fig-
ure 2). Furthermore, rSO2 showed a pattern of lower levels
in the affected hemisphere than in the nonaffected hemi-
sphere (Figure 3), thus supporting the hypothesis of a rela-
TABLE 3. Diagnostic performance indices of right and left h
values during and after the period of selective antegrade
Variable
SACP star
Right
ROC area 0.87 (0.75-1.0)
Cutoff value (% of baseline) 81
Sensitivity 0.83 (0.39-0.99)
Specificity 0.78 (0.71-0.81)
Positive predictive value 0.39 (0.18-0.46)
Negative predictive value 0.97 (0.88-1.0)
Likelihood ratio (positive) 3.9
Likelihood ratio (negative) 0.2
Odds ratio 18 (1.6-470)
Relative risk 12 (1.5-255)
Data are means with 95% confidence intervals.tionship between lower intraoperative rSO2 and periopera-
376 The Journal of Thoracic and Cardiovascular Surgery ● Febrtive stroke. A similar pattern was found when bilateral and
unilateral SACP were compared (Figure 4, A and B), with
consistently lower values in both hemispheres during uni-
lateral SACP. This contributes to the explanation of the
finding of fewer strokes with bilateral SACP. In experimen-
tal studies, longer periods of HCA equaling lower rSO2 and
prolonged periods to recovery of baseline rSO2 have been
associated with cerebral complications.6,8 Minimizing peri-
ods of HCA without SACP could be important to prevent
cerebral damage, especially when operations are performed
at moderate rather than deep hypothermia.
In assessing the diagnostic performance of the NIRS
method of monitoring rSO2, several diagnostic indices were
calculated on the basis of the recorded readings (Table 3). In
the ROC curve analysis, true-positive cases are plotted
against true-negative cases, and the resulting function de-
lineates an area, the AUC, that represents the overall per-
formance of the test. The AUC is a close approximation of
the probability that the test is correct for any given value.
Generally, the ROC curve AUC should be at least 0.75 to be
clinically valuable.17 This was the case for all but 1 left-
sided time point (mid SACP) and 1 right-sided time point
(after SACP). Right-sided readings at the beginning of
SACP and left-sided readings at the end of SACP were
singled out as the individual time points with the largest
AUC. Cutoff values for each individual time point were
determined and served as the basis for the corresponding
diagnostic indices. Cutoffs varied between 76 at the start of
SACP and 86 after SACP, with an overall mean of 83,
expressed as a percentage of baseline (100). Below these
cutoffs, the odds ratio for stroke increased to 32, and rela-
tive risk increased to 13 (Table 3). Overall, sensitivity was
higher than specificity (Table 3). Furthermore, negative
predictive values and positive likelihood ratios were higher
than positive predictive values and negative likelihood ra-
spheric relative regional cerebral tissue oxygen saturation
bral perfusion (SACP)
SACP mid
Left Right Left
5 (0.52-1.0) 0.79 (0.62-0.97) 0.72 (0.54-0.90)
76 87 86
3 (0.39-0.99) 0.80 (0.18-0.92) 0.80 (0.32-0.99)
1 (0.74-0.84) 0.89 (0.83-0.93) 0.58 (0.52-0.61)
2 (0.20-0.50) 0.43 (0.13-0.66) 0.21 (0.08-0.26)
7 (0.88-1.0) 0.94 (0.88-0.99) 0.96 (0.84-1.0)
4.4 5.2 1.9
0.2 0.4 0.3
1 (1.8-566) 12 (1.1-157) 5.6 (0.5-144)
3 (1.7-286) 7.1 (1.1-54) 4.6 (0.5-107)emi
cere
t
0.7
0.8
0.8
0.4
0.9
2
1tios. These are key findings indicating that episodes of
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a proportion of false-positive cases. We find it better to err
on the side of sensitivity and adjust cannulas, flow, temper-
ature, and the surgical approach to try to correct a low rSO2.
The NIRS monitor also rapidly identified perfusion-related
problems that otherwise could be very harmful yet go
undetected.
Our findings corroborate those of Samra and associ-
ates,18 who studied 99 patients undergoing carotid endar-
terectomy with bilateral NIRS monitoring. They reported a
larger decrease of ipsilateral rSO2 (12.2% vs 4.8%) during
crossclamping of the carotid artery in patients with postop-
erative neurologic symptoms, and they identified a cutoff
point of a 20% decrease from baseline: this yielded an 80%
sensitivity and 82.2% specificity but a 66.7% false-positive
rate. Orihashi and colleagues4 studied rSO2 in 59 patients
undergoing aortic arch operations with SACP. In 16 patients
(27%) with cerebral complications, they found sustained
periods of rSO2 less than 55% or 60%, which were cutoffs
chosen from accepted lowest values of jugular vein bulb
venous saturation and estimated “normal” cerebral tissue
saturation. It is interesting to note that their findings applied
only to patients who sustained cerebral damage attributable
to hypoperfusion; according to the authors, embolic strokes
went undetected by rSO2. In other studies, it has been
shown that rSO2 remains at baseline in patients without
cerebral complications5 and that a decline in rSO2 of ap-
proximately 40% is associated with impaired neuropsycho-
logical performance.19 Kirkpatrick and colleagues20 dem-
onstrated in neurosurgical patients that a desaturation in the
magnitude of 25% to 30% (from a baseline of 75%) corre-
sponded to an episode of severe cerebral ischemia. Evi-
dently, studies in different patient populations are coherent
in their findings of a critical rSO2 level in the interval of
25% to 40% below baseline, or approximately 50% in rSO2
SACP end
Right Left
0.76 (0.57-0.96) 0.83 (0.67-0.98)
81 84
0.67 (0.26-0.94) 0.83 (0.39-0.99)
0.85 (0.78-0.90) 0.76 (0.68-0.79)
0.44 (0.18-0.62) 0.39 (0.18-0.46)
0.93 (0.85-0.99) 0.96 (0.86-1.0)
4.4 3.4
0.4 0.2
11 (1.2-127) 16 (1.4-407)
6.7 (1.2-49) 10 (1.3-221)index readings. Our results support these findings and add
The Journal of Thoracifurther support to their application by introducing data
regarding the diagnostic performance of the NIRS method.
In our opinion, the diagnostic performance of intraoperative
NIRS monitoring, although not perfect, is good enough to
recommend its clinical use both to guide the conduct of
cerebral perfusion and to predict perioperative stroke.
Despite theoretical concerns about the NIRS method—
specifically, its ability to adequately monitor cerebral tissue
rather than the overlying structures21—there are several
reports that support its use, demonstrating good correlations
between rSO2 and magnetic resonance findings,22 histologic
findings,6,8,23 alterations in cerebral and systemic biochem-
ical markers of tissue damage,8 and jugular vein bulb ve-
nous saturation,5,24 a method assumed to represent the over-
all oxygen consumption of the brain. To the best of our
knowledge, none of the mentioned methods has been fully
evaluated as a diagnostic test by using the indices of this
report, which are considered essential for an evidence-based
use of a diagnostic instrument.
Arterial blood gases, mean arterial pressures, and he-
matocrit correlated only weakly and insignificantly with
rSO2 irrespective of the phase of the operation (Table
E1). These findings in part differ from those of Nollert
and associates,25 who report correlations of rSO2 with
pCO2 and also of oxidized cytochrome to pH, tempera-
ture, and hemoglobin. However, most of their patients
underwent coronary surgery and other operations with
standard CPB. Patients underwent operation under mod-
erate hypothermia (26°C). Aortic surgery and SACP were
not represented, and NIRS monitoring was unilateral (left
hemisphere). It is interesting to note that rSO2 showed a
correlation with measured variables only during CPB. No
patient experienced stroke after surgery, and the ability of
rSO2 to predict stroke could not be evaluated. In our opin-
ion, standard intraoperative monitoring does not adequately
After SACP
Right Left
0.74 (0.54-0.93) 0.82 (0.64-1.0)
91 77
0.83 (0.39-0.99) 0.67 (0.27-0.91)
0.74 (0.66-0.76) 0.94 (0.87-0.99)
0.36 (0.17-0.43) 0.67 (0.27-0.91)
0.96 (0.86-1.0) 0.94 (0.87-0.99)
3.1 11.3
0.2 0.3
14 (1.2-457) 32 (2.5-667)
9.3 (1.2-206) 11 (2.1-59)represent cerebral tissue saturation; it does not predict neu-
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monitoring the brain directly.
There are several limitations of this study. It includes a
small number of patients. Some of the data were collected
retrospectively. Patients were not randomized to the differ-
ent SACP strategies, and there is no control group for
comparison of NIRS data. Some important variables, eg,
hematocrit, were not included in the analysis. The findings
of this study need to be confirmed in larger, well-designed
studies, preferably studies that use continuous intraopera-
tive NIRS data.
In summary, the application of NIRS to measure rSO2 in
cerebral tissue during SACP seems to provide important
information that can be used to improve intraoperative
perfusion performance and to predict perioperative neuro-
logic outcome. The diagnostic properties of the method are
good but not perfect. Information during the initiation of
SACP, specifically at moderate hypothermia when the brain
is not perfused, is the most important. Standard intraopera-
tive monitoring correlates poorly with rSO2 and cannot
replace its use. Knowledge of critical rSO2 levels and diag-
nostic performance is fundamental to the application of the
method, and we anticipate a more widespread use that
includes broader patient groups and further technical ad-
vancements of the monitoring devices.
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Discussion
Dr G. Michael Deeb (Ann Arbor, Mich). I would like to commend
the authors for this interesting and thought-provoking presentation.
There are 3 areas that I would like to address for discussion.
The first area for discussion is your definition of stroke. Since
the ability of a tool to measure the outcome will be dependent on
a clear definition, I would like the definition of stroke used in this
study. Was it a clinical diagnosis, or was the diagnosis made on the
results of an imaging study? Did you have a good thorough
neurologic preoperative clinical examination and/or imaging study
to use for postoperative comparison?
Dr Olsson. Many of these patients underwent emergency
surgery for dissection, and time did not allow preoperative
studies regarding cerebral imaging. So the answer to that ques-
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clinical one.
Dr Deeb. Did you have any patients who were intubated and
asleep preoperatively so you couldn’t perform a neurologic eval-
uation? If you did, how did you determine whether the stroke had
happened preoperatively or perioperatively?
Dr Olsson. We did not have any preoperatively intubated
patients, and as far as we could judge, we didn’t deem any of them
to have a clinically obvious stroke preoperatively.
Dr Deeb. The second area that I wanted to address was your
sample sizes. I was forced to consider sample size as I was looking
at your preoperative comparison of patient characteristics between
stroke and nonstroke patients, where you stated there was no
significant statistical difference between the 2 groups. Yet looking
at the data, I thought there was definite clinical significance.
For instance, the difference between the number of patients
with a dissection in the 2 groups was 33%. The difference in the
number of patients with a rupture was about 38%. So there were
some large numbers that were glaring that didn’t have statistical
significance but seemed to have clinical significance, and I was
wondering if there was a tendency toward a type II statistical error
secondary to sample size.
The other reason I questioned the sample size was that if you
look at your indices that you used to calculate the areas under the
curve for your ROC curves, you used sensitivity and specificity
and stated that sensitivity was your most accurate tool, yet the
confidence intervals for your sensitivity were very wide, as well as
the confidence intervals for your odds ratios. Could you address
this issue?
Dr Olsson. Dr Deeb, I think you already have. Of course, the
sample sizes are small in this study, and we have to understand that
certain conclusions cannot be drawn statistically. But all these
indices are intertwined, and they all point in the same direction,
lending some support to the idea that what we see is probably
close to the truth, even if the statistical evidence for it could be
questioned.
Dr Deeb. My last area for discussion is something that was
very intriguing to me. When I looked at the patients who had
stroke versus those who did not, the glaring difference was sub-
optimal perfusion. You showed in your tables that none of your
patients with stroke had optimal perfusion. You defined optimal
flow versus suboptimal flow based on the incidence of bilateral
perfusion, whether there was uninterrupted perfusion, as well as
the amount of time perfused in relationship to the incidence of
stroke. On your review, none of your stroke patients had optimal
perfusion. All of the patients who had optimal perfusion did not
stroke, which was interesting, and your mean circulatory arrest
time was less than 40 minutes.
There are series in the literature which show patients having
hypothermic circulatory arrest with no perfusion at all with mean
circulatory arrest times less than 40 minutes that have stroke rates
8% or less. If you put infrared spectroscopy on these patients, they
have a distinct drop in their saturation, which is continual and
progressive. Yet in your series with antegrade cerebral perfusion,
your stroke rate was 13%. Therefore, in hypothermic circulatory
arrest less than 40 minutes, is suboptimal perfusion worse than no
The Journal of Thoraciperfusion? Also, in the instances of no perfusion with infrared
spectroscopy which shows a continual dramatic drop, why do these
patients, over 90% of them, not have stroke? What is the sensi-
tivity of infrared spectroscopy in this incidence, and how can you
correlate it to the published results?
Dr Olsson. I am not completely sure that I know what you are
getting at. First of all, I would like to say what is not shown among
these figures is the fact that in an instance perhaps where you start
the cerebral perfusion and immediately detect a drop on one side,
we have adjusted, for example, the cannula placement to look for
kinking and so on and handled that problem immediately, and
these instances will not show on the figures, of course. I don’t
know if that is what you are getting at when you are talking about
suboptimal perfusion in stroke patients.
Dr Deeb. What I was getting at was the use of suboptimal
cerebral perfusion during hypothermic circulatory arrest. You were
so kind as to give me the manuscript, and you had the definitions
for suboptimal and optimal perfusion. On the basis of your data
with hypothermic circulatory arrest with a mean time less than 40
minutes using antegrade cerebral perfusion with a 13% stroke rate
and comparing these data with previous data published showing
hypothermic circulatory arrest with a mean time less than 40
minutes and no cerebral perfusion with a stroke rate of 8%, maybe
suboptimal perfusion is more dangerous than no cerebral perfusion
for hypothermic circulatory arrest less than 40 minutes.
Dr Olsson. That is an intriguing idea, and without having any
evidence for it, many would certainly advocate the opinion that if
you have an anticipated circulatory arrest shorter than the time it
would take to establish the cerebral perfusion, you should go for
circulatory arrest alone.
Dr Joseph Bavaria (Philadelphia, Pa). I enjoyed your talk.
We, like you, are using NIRS for most of our cases. For some case,
we have noticed immediate changes in the NIRS, and they have
really helped us avoid a catastrophe, especially with direct cannu-
lation of the arch vessels like the Kazui technique. However, what
I wanted to address with you is the idea of relativity between the
left and right or the bilaterality of these numbers. Your conclusion
slide said that between a 14% and 24% reduction in the NIRS from
baseline was a sign of concern. If you had both sides with, say, a
14% reduction, would you be worried, or is it just really a unilat-
eral issue that you are most worried about?
Dr Olsson. I would be equally worried in both instances, I
think. If such a decrease in NIRS readings of that magnitude
occurred unilaterally or bilaterally, I would be concerned.
Dr Teruhisa Kazui (Hamamatsu, Japan). Why did the rSO2
fall after the institution of the CPB and before the beginning of the
SACP in the patients with stroke? Does it reflect the malperfusion
due to the dissection or retrograde embolization from the distal
aorta after the disappearance of the cardiac pulsation?
Dr Olsson. That is something we cannot be sure of as we have
believed during the course of the operations we have not had any
instance of, for example, cannulation-related malperfusion. How-
ever, we do not know what damage the dissection itself has already
made, and it could be a possible explanation for several or all of
these strokes.
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Sensitivity, the ability of a test to accurately identify disease:
True positive True positive  false negative.
Specificity, the ability of a test to accurately exclude disease:
True negative True negative  false positive.
Positive predictive value, proportion of patients with a pos-
itive test who have the disease: True positive  True positive 
false positive Assesses the reliability of a positive test.
Negative predictive value, proportion of patients with a negative379.e1 The Journal of Thoracic and Cardiovascular Surgery ● Fetest who do not have the disease: True negative True negative 
false negative. Assesses the reliability of a negative test.
Positive likelihood ratio (LR), the odds of a positive test
result in a patient with the disease by the odds of a positive test in
a patient without the disease: Sensitivity  1  specificity. If
LR increases, the ability to diagnose the disease increases.
Negative likelihood ratio (LR), the odds of a negative test
result in patient with the disease by the odds of a negative test in
a patient without the disease: 1 sensitivity  specificity. If LR
decreases, the ability to exclude the disease increases.bruary 2006
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CDTABLE E1. Arterial blood gas measurements and mean arterial blood pressure before CPB, on CPB, after SACP, at end of
CPB, and after CPB in patients without versus with stroke
Correlation (r)*
Variable No stroke (n  40) Stroke (n  6) P value rSO2 right rSO2 left
Before CPB
pH 7.39 (0.05) 7.37 (0.07) .58 0.03 0.18
PaO2 (mm Hg) 84.8 (65.3) 96.0 (57.0) .21 0.005 0.04
PaCO2 (mm Hg) 39.7 (8.6) 38.4 (8.0) .63 0.17 0.26
SaO2 (%) 97 (5) 98 (4) .24 0.00 0.06
Hematocrit (%) 38 (9) 36 (4) .30 0.30 0.20
MAP (mm Hg) 84 (22) 63 (25) .08 0.20 0.23
On CPB
pH 7.38 (0.08) 7.34 (0.19) .79 0.23 0.20
PaO2 (mm Hg) 206.3 (76.5) 180.0 (129.0) .83 0.23 0.16
PaCO2 (mm Hg) 39.7 (10.9) 37.9 (11.7) .28 0.37† 0.33†
SaO2 (%) 100 (0) 99 (1) .16 0.34† 0.24
Hematocrit (%) 26 (6) 24 (6) .33 0.27 0.28
MAP (mm Hg) 55 (10) 50 (15) .83 0.14 0.17
After SACP
pH 7.29 (0.15) 7.23 (0.18) .37 0.06 0.02
PaO2 (mm Hg) 208.5 (90.0) 232.5 (63.0) .40 0.39† 0.44†
PaCO2 (mm Hg) 41.1 (13.6) 45.7 (10.1) .13 0.16 0.01
SaO2 (%) 100 (1) 99 (1) .53 0.00 0.00
Hematocrit (%) 26 (6) 24 (6) .75 0.29 0.37†
MAP (mm Hg) 50 (20) 50 (15) .59 0.27 0.33†
End of CPB
pH 7.38 (0.07) 7.37 (0.11) .60 0.06 0.13
PaO2 (mm Hg) 177.0 (86.3) 243.0 (202.5) .15 0.11 0.20
PaCO2 (mm Hg) 35.2 (3.7) 36.4 (6.3) .96 0.02 0.24
SaO2 (%) 100 (0.5) 100 (1) .78 0.14 0.28
Hematocrit (%) 27 (4) 27 (5) .73 0.06 0.06
MAP (mm Hg) 60 (9) 55 (10) .24 0.03 0.00
After CPB
pH 7.39 (0.08) 7.39 (0.05) .26 0.18 0.30
PaO2 (mm Hg) 111.8 (92.2) 144.8 (62.3) .21 0.35 0.20
PaCO2 (mm Hg) 36.8 (7.0) 38.7 (3.7) .26 0.18 0.11
SaO2 (%) 99 (3.5) 99 (1) .36 0.35 0.14
Hematocrit (%) 30 (7) 30 (8) .78 0.24 0.11
MAP (mm Hg) 64 (10) 63 (14) .94 0.05 0.16
Data are median (interquartile range). CPB, Cardiopulmonary bypass; SACP, selective antegrade cerebral perfusion; PaO2 , arterial partial tension of oxygen;
PaCO2 , arterial partial tension of carbon dioxide; SaO2 , arterial oxygen saturation; MAP, mean arterial pressure; rSO2 , regional cerebral tissue oxygen
saturation. *Correlation between rSO2 and variable in patients without stroke. †P  .05.The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 2 379.e2
